Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol versus clonazepam in adults with generalized anxiety disorder
RBR-2fw8kgPhase 4Not yet recruiting
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cannabidiol and clonazepam in generalized anxiety disorder (GAD) (2 arms), sponsored by Faculdade de Medicina de Ribeirão Preto. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
cannabidiolclonazepam
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on RBR-2fw8kg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2fw8kg.